Bethany Roderer
Nurse Practitioner · Silver Spring, MDNPI 1730458571
Payments from drug & device makers
Across 101 payments — averaging $21.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$267
- Johnson & Johnson$224
- Incyte Corporation$167
- Astellas Pharma US Inc$143
- AstraZeneca$110
- Takeda Pharmaceuticals U.S.A., Inc.$92
- plus $1K from 33 others
What the payments were for
- Food & beverage$1,89189%
- Education$24111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 13 | $267 |
| Johnson & Johnson(2 entities) | 11 | $224 |
| Incyte Corporation | 5 | $167 |
| Astellas Pharma US Inc | 4 | $143 |
| AstraZeneca(2 entities) | 6 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $92 |
| Lilly USA, LLC | 5 | $73 |
| Merck | 4 | $71 |
| Sanofi | 3 | $65 |
| Bayer | 4 | $62 |
| Seagen Inc. | 3 | $60 |
| Rigel Pharmaceuticals, Inc. | 1 | $58 |
| Taiho Oncology, Inc. | 3 | $58 |
| GSK | 2 | $53 |
| Eisai Inc. | 3 | $50 |
| Global Blood Therapeutics, Inc. | 2 | $49 |
| Bristol Myers Squibb | 2 | $41 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Acceleron Pharma, Inc. | 2 | $34 |
| AbbVie | 2 | $33 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $30 |
| Amgen | 2 | $29 |
| Boehringer Ingelheim | 1 | $28 |
| Beigene USA, Inc. | 1 | $26 |
| Clovis Oncology, Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $20 |
| Morphosys, US Inc. | 1 | $19 |
| Deciphera Pharmaceuticals Inc. | 1 | $19 |
| Puma Biotechnology, Inc. | 1 | $18 |
| Exelixis Inc. | 1 | $18 |
| Stemline Therapeutics Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Servier Pharmaceuticals LLC | 1 | $16 |
| Dova Pharmaceuticals | 1 | $16 |
| Acrotech Biopharma Inc. | 1 | $13 |
| Emmaus Medical, Inc. | 1 | $12 |
How this compares
$2,132 in reported general payments places this provider in the 90th percentile of 1,562 nurse practitioner providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 11 | $44 |
| Sertraline Hcl | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Silver Spring
- Marianne WoodySilver Spring$5K
- Morgan GaleRockville$292K
- Sherilyn BrinkleyBaltimore$100K
- Michelle TurnerBaltimore$94K
- Nelli ZafmanLutherville$67K
- Ellen LancasterFallston$52K
- Doris TateEaston$34K
- Zeev NemirovskyBaltimore$19K
- Martha ReilleyAnnapolis$18K
- Stephanie ZwonitzerAnnapolis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.